ReviewaBIOTECH2020
Achieving broad-spectrum resistance against rice bacterial blight through targeted promoter editing and pathogen population monitoring.
Review in aBIOTECH, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 citations in OpenAlex.
- Transcriptome and Metabolome Analysis of Rice Cultivar CBB23 after Inoculation byPlants (Basel, Switzerland) · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Plant diseases severely reduce crop yields and threaten global food security. Broad-spectrum resistance (BSR) is a desirable trait because it confers resistance against more than one pathogen species or the majority of races/strains of the same pathogen. To control plant diseases, breeders have selected BSR to reduce disease occurrence and prolong the life-span of newly released cultivars in the last several decades (Mundt, Phytopathology 108(7):792-802, 2018). Although effective, breeding of BSR cultivars in crop plants is still time-consuming and technically challenging. Recently, new gene-editing technologies such as CRISPR/Cas9 have dramatically accelerated the process of plant breeding and provided an approach for rapidly creating new varieties with BSR and other beneficial traits (Borrelli et al., Front Plant Sci 9:1245, 2018). In addition, close surveillance of pathogen populations in the field can provide useful information for the deployment of appropriate resistance genes in the target regions. In this mini-review, we focus on the significance and application of the exciting results from two recent companion papers published in
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.